<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36232592</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11291</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231911291</ELocationID><Abstract><AbstractText>Long-term neurological and mental complications of COVID-19, the so-called post-COVID syndrome or long COVID, affect the quality of life. The most persistent manifestations of long COVID include fatigue, anosmia/hyposmia, insomnia, depression/anxiety, and memory/attention deficits. The physiological basis of neurological and psychiatric disorders is still poorly understood. This review summarizes the current knowledge of neurological sequelae in post-COVID patients and discusses brain demyelination as a possible mechanism of these complications with a focus on neuroimaging findings. Numerous reviews, experimental and theoretical studies consider brain demyelination as one of the mechanisms of the central neural system impairment. Several factors might cause demyelination, such as inflammation, direct effect of the virus on oligodendrocytes, and cerebrovascular disorders, inducing myelin damage. There is a contradiction between the solid fundamental basis underlying demyelination as the mechanism of the neurological injuries and relatively little published clinical evidence related to demyelination in COVID-19 patients. The reason for this probably lies in the fact that most clinical studies used conventional MRI techniques, which can detect only large, clearly visible demyelinating lesions. A very limited number of studies use specific methods for myelin quantification detected changes in the white matter tracts 3 and 10 months after the acute phase of COVID-19. Future research applying quantitative MRI assessment of myelin in combination with neurological and psychological studies will help in understanding the mechanisms of post-COVID complications associated with demyelination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khodanovich</LastName><ForeName>Marina Y</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0003-1856-0674</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 634050 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamaeva</LastName><ForeName>Daria A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-2760-0252</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 634050 Tomsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Genetics and Biochemistry, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naumova</LastName><ForeName>Anna V</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0002-4021-5343</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Research Institute of Biology and Biophysics, Tomsk State University, 634050 Tomsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22-15-00481</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="Y">Attention Deficit Disorder with Hyperactivity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="Y">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">demyelination</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental sequelae</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword><Keyword MajorTopicYN="N">neurological consequences</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36232592</ArticleId><ArticleId IdType="pmc">PMC9569975</ArticleId><ArticleId IdType="doi">10.3390/ijms231911291</ArticleId><ArticleId IdType="pii">ijms231911291</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P., Renisi G., Signorini L., Migliorati K., Fontanella M.M. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162:1491&#x2013;1494. doi: 10.1007/s00701-020-04374-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J., Frosch M.P., Mukerji S.S., Rapalino O., Maher M.D., Schaefer P.W., Lev M.H., Gonzalez R.G., Das S., Champion S.N., et al. Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J. Neurol. Sci. 2021;421:117308. doi: 10.1016/j.jns.2021.117308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117308</ArticleId><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Patel S., Gentleman S., Matthews P.M., Floor T., Danes B. Neurological Consequences of COVID-19 Infection. arXiv. 20212106.05388</Citation></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Investig. 2021;131:e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Najt P., Richards H.L., Fortune D.G. Brain imaging in patients with COVID-19: A systematic review. Brain, Behav. Immun.-Health. 2021;16:100290. doi: 10.1016/j.bbih.2021.100290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100290</ArticleId><ArticleId IdType="pmc">PMC8249107</ArticleId><ArticleId IdType="pubmed">34230916</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin G.A., Snyder H., Carrillo M., Hosseini A.A., Brugha T.S., Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer&#x2019;s Dement. 2021;17:1056&#x2013;1065. doi: 10.1002/alz.12255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter A.G., Shields A.M., Karim A., Birch D., Faustini S.E., Steadman L., Ward K., Plant T., Reynolds G., Veenith T., et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin. Exp. Immunol. 2021;205:99&#x2013;105. doi: 10.1111/cei.13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13623</ArticleId><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M.E., Madore C., Bordeleau M., Tian L., Verkhratsky A. Neuropathobiology of COVID-19: The Role for Glia. Front. Cell. Neurosci. 2020;14:592214. doi: 10.3389/fncel.2020.592214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.592214</ArticleId><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonis G., Filippi C.G., Kirsch C.F.E., Mohan S., Stein E.G., Hirsch J.A., Mahajan A. The Spectrum of Neuroimaging Findings on CT and MRI in Adults with COVID-19. Am. J. Roentgenol. 2021;217:959&#x2013;974. doi: 10.2214/AJR.20.24839.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.20.24839</ArticleId><ArticleId IdType="pubmed">33236647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladecola C., Anrather J., Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183:16&#x2013;27. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalakshmi A.M., Ray B., Tuladhar S., Bhat A., Paneyala S., Patteswari D., Sakharkar M.K., Hamdan H., Ojcius D.M., Bolla S.R., et al. Does COVID-19 contribute to development of neurological disease? Immun. Inflamm. Dis. 2021;9:48&#x2013;58. doi: 10.1002/iid3.387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.387</ArticleId><ArticleId IdType="pmc">PMC7860611</ArticleId><ArticleId IdType="pubmed">33332737</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol. Belg. 2021;121:859&#x2013;866. doi: 10.1007/s13760-021-01691-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01691-5</ArticleId><ArticleId IdType="pmc">PMC8088756</ArticleId><ArticleId IdType="pubmed">33934300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougakov D., Podell K., Goldberg E. Multiple Neuroinvasive Pathways in COVID-19 The Current COVID-19 Pandemic. Mol. Neurobiol. 2021;58:564&#x2013;575. doi: 10.1007/s12035-020-02152-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02152-5</ArticleId><ArticleId IdType="pmc">PMC7523266</ArticleId><ArticleId IdType="pubmed">32990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Vendramini P.H., Valen&#xe7;a G.F., Saraiva A., Marcelo L., Brand&#xe3;o-teles C., Silva G., Reis-de-oliveira G., et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. MedRxiv. 2021 doi: 10.1101/2020.10.09.20207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah F., Myers J., Basu D., Tintinger G., Ueckermann V., Mathebula M., Ramlall R., Spoor S., de Villiers T., Van der Walt Z., et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int. J. Infect. Dis. 2022;116:38&#x2013;42. doi: 10.1016/j.ijid.2021.12.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.357</ArticleId><ArticleId IdType="pmc">PMC8713416</ArticleId><ArticleId IdType="pubmed">34971823</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T., Ferguson N.M., Nash S.G., Webster H.H., Flaxman S., Andrews N., Hinsley W., Bernal J.L., Kall M., Bhatt S., et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: A cohort study. Lancet. 2022;399:1303&#x2013;1312. doi: 10.1016/S0140-6736(22)00462-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. World Health Organization (WHO), WHO Press; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Stefanou M.I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson C.J., Sarangi A., Bangash F. Neurological sequelae of COVID-19: A review. Egypt. J. Neurol. Psychiatry Neurosurg. 2021;57:122. doi: 10.1186/s41983-021-00379-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-021-00379-0</ArticleId><ArticleId IdType="pmc">PMC8424148</ArticleId><ArticleId IdType="pubmed">34511868</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.-I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S., Tsoporis J., Spandidos D., et al. Long COVID and neuropsychiatric manifestations . Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R., Hemminghyth M.S., Eilertsen T.H., Breitve M.H., Chwiszczuk L.J. Cognitive Impairment After COVID-19&#x2014;A Review on Objective Test Data. Front. Neurol. 2021;12:699582. doi: 10.3389/fneur.2021.699582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhola S., Trisal J., Thakur V., Kaur P., Kulshrestha S., Bhatia S.K., Kumar P. Neurological toll of COVID-19. Neurol. Sci. 2022;43:2171&#x2013;2186. doi: 10.1007/s10072-022-05875-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-05875-6</ArticleId><ArticleId IdType="pmc">PMC8761097</ArticleId><ArticleId IdType="pubmed">35034236</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R., Hussein M. Could SARS-CoV-2 Infection Be a Novel Risk Factor for Multiple Sclerosis? Neuroimmunomodulation. 2022 doi: 10.1159/000521891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521891</ArticleId><ArticleId IdType="pmc">PMC9059011</ArticleId><ArticleId IdType="pubmed">35235939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskin D. COVID-19-associated CNS Demyelinating Diseases Let us know how access to this document benefits you.  [(accessed on 20 September 2022)];Thomas Jefferson Univ. Dep. Neurosci. Fac. Pap. 2020 Paper 48 Available online:  https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1048&amp;context=department_neuroscience.</Citation></Reference><Reference><Citation>Zoghi A., Ramezani M., Roozbeh M., Darazam I.A., Sahraian M.A. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult. Scler. Relat. Disord. 2020;44:102324. doi: 10.1016/j.msard.2020.102324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102324</ArticleId><ArticleId IdType="pmc">PMC7311915</ArticleId><ArticleId IdType="pubmed">32615528</ArticleId></ArticleIdList></Reference><Reference><Citation>Karapanayiotides T., Geka E., Prassopoulos P., Koutroulou I., Kollaras P., Kiourtzieva E., Pourzitaki C., Veroniki F., Sintila S.A., Astreinidis A., et al. Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: A lurking catastrophe? Brain. 2021;143:e100. doi: 10.1093/brain/awaa375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa375</ArticleId><ArticleId IdType="pmc">PMC7665315</ArticleId><ArticleId IdType="pubmed">33064796</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandelwal K., Puranik M., Gupta V., Khandelwal G., Dave P.K., Hirve M. COVID-19 associated acute demyelination masquerading as stroke: A case report. Egypt. J. Radiol. Nucl. Med. 2021;52:32. doi: 10.1186/s43055-021-00410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-021-00410-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima M., Aloizou A.M., Siokas V., Bakirtzis C., Liampas I., Tsouris Z., Bogdanos D.P., Baloyannis S.J., Dardiotis E. Coronaviruses and their relationship with multiple sclerosis: Is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev. Neurosci. 2022 doi: 10.1515/revneuro-2021-0148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2021-0148</ArticleId><ArticleId IdType="pubmed">35258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail I.I., Salama S. Association of CNS Demyelination and COVID-19 Infection: An Updated Systematic Review. Volume 269. Springer; Berlin/Heidelberg, Germany: 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359762</ArticleId><ArticleId IdType="pubmed">34386902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracaglia M., Naldi I., Govoni A., Brillanti Ventura D., De Massis P. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2. J. Neurol. 2020;267:3166&#x2013;3168. doi: 10.1007/s00415-020-10014-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10014-2</ArticleId><ArticleId IdType="pmc">PMC7315403</ArticleId><ArticleId IdType="pubmed">32588185</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and Health Outcomes among Survivors of COVID-19 Infection 1 Year after Discharge from Hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Lana S., Marqui&#xe9; M., Ruiz A., Boada M. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front. Aging Neurosci. 2020;12:588872. doi: 10.3389/fnagi.2020.588872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.588872</ArticleId><ArticleId IdType="pmc">PMC7649130</ArticleId><ArticleId IdType="pubmed">33192483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharun K., Dhama K., Pawde A.M., Gort&#xe1;zar C., Tiwari R., Bonilla-Aldana D.K., Rodriguez-Morales A.J., de la Fuente J., Michalak I., Attia Y.A. SARS-CoV-2 in animals: Potential for unknown reservoir hosts and public health implications. Vet. Q. 2021;41:181&#x2013;201. doi: 10.1080/01652176.2021.1921311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01652176.2021.1921311</ArticleId><ArticleId IdType="pmc">PMC8128218</ArticleId><ArticleId IdType="pubmed">33892621</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2020;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. eClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T., Borzikowsky C., Lieb W., Horn A., Krist L., Fricke J., Scheibenbogen C., Rabe K.F., Maetzler W., Maetzler C., et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. eClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk factors associated with long covid syndrome: A retrospective study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Sui Ko A., Candellier A., Mercier M., Joseph C., Schmit J.L., Lanoix J.P., Andrejak C. Number of initial symptoms is more related to long COVID-19 than acute severity of infection: A prospective cohort of hospitalized patients. Int. J. Infect. Dis. 2022;118:220&#x2013;223. doi: 10.1016/j.ijid.2022.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.006</ArticleId><ArticleId IdType="pmc">PMC8896858</ArticleId><ArticleId IdType="pubmed">35257903</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W.L., de Souza A.C.C., Borges J.W.P., Oliveira D.N., Siqueira-Neto J.I., Sobreira-Neto M.A., Braga-Neto P. COVID-19 associated cognitive impairment: A systematic review. Cortex. 2022;152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Light S.N. The Combined Use of Neuropsychiatric and Neuropsychological Assessment Tools to Make a Differential Dementia Diagnosis in the Presence of &#x201c;long-Haul&#x201d; COVID-19. Case Rep. Neurol. 2022;14:130&#x2013;148. doi: 10.1159/000522020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522020</ArticleId><ArticleId IdType="pmc">PMC8958594</ArticleId><ArticleId IdType="pubmed">35431881</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolland Y., Baziard M. Coronavirus Disease-2019 in Older People with Cognitive Impairment. Clin. Geriatr. Med. 2022;38:501&#x2013;517. doi: 10.1016/j.cger.2022.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.03.002</ArticleId><ArticleId IdType="pmc">PMC8934719</ArticleId><ArticleId IdType="pubmed">35868669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Putri C., Arisa J., Situmeang R.F.V., Kurniawan A. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis. Arch. Gerontol. Geriatr. 2021;93:104299. doi: 10.1016/j.archger.2020.104299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2020.104299</ArticleId><ArticleId IdType="pmc">PMC7674980</ArticleId><ArticleId IdType="pubmed">33285424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.L., Pilling L.C., Atkins J.L., Masoli J.A.H., Delgado J., Kuchel G.A., Melzer D., Newman A.B. ApoE e4e4 Genotype and Mortality with COVID-19 in UK Biobank. J. Gerontol.-Ser. A Biol. Sci. Med. Sci. 2020;75:1801&#x2013;1803. doi: 10.1093/gerona/glaa169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa169</ArticleId><ArticleId IdType="pmc">PMC7337688</ArticleId><ArticleId IdType="pubmed">32623451</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop-Vicas A., Osman F., Tsaras G., Seigworth C., Munoz-Price L.S., Safdar N. Predictors of Persistent Symptoms after SARS-CoV-2 Infection among Healthcare Workers: Results of a Multi-site Survey. Infect. Control Hosp. Epidemiol. 2022;2:1&#x2013;4. doi: 10.1017/ice.2022.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2022.56</ArticleId><ArticleId IdType="pmc">PMC9021585</ArticleId><ArticleId IdType="pubmed">35383550</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T., Wu J., Chen T., Li J., Yan S., Zhou Y., Peng X., Li Y., Zheng N., Cai A., et al. Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. 2022;7:e155827. doi: 10.1172/jci.insight.155827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogier M., And&#xe9;ol G., Sagui E., Dal Bo G. How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav. Immun.-Health. 2020;5:100081. doi: 10.1016/j.bbih.2020.100081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100081</ArticleId><ArticleId IdType="pmc">PMC7227537</ArticleId><ArticleId IdType="pubmed">32427134</ArticleId></ArticleIdList></Reference><Reference><Citation>Papuc E., Rejdak K. The role of myelin damage in Alzheimer&#x2019;s disease pathology. Arch. Med. Sci. 2020;16:345&#x2013;351. doi: 10.5114/aoms.2018.76863.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2018.76863</ArticleId><ArticleId IdType="pmc">PMC7069444</ArticleId><ArticleId IdType="pubmed">32190145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dendrou C.A., Fugger L., Friese M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015;15:545&#x2013;558. doi: 10.1038/nri3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3871</ArticleId><ArticleId IdType="pubmed">26250739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon-Caen O., Jouvent R., Hauser S., Chaunu M.P., Benoit N., Widl&#xf6;cher D., Lhermitte F. Cognitive Function in Recent-Onset Demyelinating Diseases. Arch. Neurol. 1986;43:1138&#x2013;1141. doi: 10.1001/archneur.1986.00520110034010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1986.00520110034010</ArticleId><ArticleId IdType="pubmed">3778246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaravalloti N.D., DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139&#x2013;1151. doi: 10.1016/S1474-4422(08)70259-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70259-X</ArticleId><ArticleId IdType="pubmed">19007738</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanholo K.R., Pitombeira M.S., Rimkus C.M., Mendes M.F., Ap&#xf3;stolos-Pereira S.L., Busatto Filho G., Callegaro D., Buchpiguel C.A., Duran F.L.S., De Paula Faria D. Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study. Mult. Scler. Relat. Disord. 2022;57:103331. doi: 10.1016/j.msard.2021.103331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103331</ArticleId><ArticleId IdType="pubmed">35158445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhrara M., Reiter D.A., Bergeron C.M., Zukley L.M., Ferrucci L., Resnick S.M., Spencer R.G. Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimer&#x2019;s Dement. 2018;14:998&#x2013;1004. doi: 10.1016/j.jalz.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.03.007</ArticleId><ArticleId IdType="pmc">PMC6097903</ArticleId><ArticleId IdType="pubmed">29679574</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X., Xu G., Wang J., Yin N., Meng N. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study. Mult. Scler. Relat. Disord. 2022;65:103838. doi: 10.1016/j.msard.2022.103838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2022.103838</ArticleId><ArticleId IdType="pubmed">35749960</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schependom J., Nagels G. Targeting cognitive impairment in multiple sclerosis-the road toward an imaging-based biomarker. Front. Neurosci. 2017;11:2012&#x2013;2017. doi: 10.3389/fnins.2017.00380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00380</ArticleId><ArticleId IdType="pmc">PMC5491975</ArticleId><ArticleId IdType="pubmed">28713238</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict R.H.B., Weinstock-Guttman B., Fishman I., Sharma J., Tjoa C.W., Bakshi R. Prediction of Neuropsychological Impairment in Multiple Sclerosis. Arch. Neurol. 2004;61:226. doi: 10.1001/archneur.61.2.226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.61.2.226</ArticleId><ArticleId IdType="pubmed">14967771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulst H.E., Steenwijk M.D., Versteeg A., Pouwels P.J.W., Vrenken H., Uitdehaag B.M.J., Polman C.H., Geurts J.J.G., Barkhof F. Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions. Neurology. 2013;80:1025&#x2013;1032. doi: 10.1212/WNL.0b013e31828726cc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828726cc</ArticleId><ArticleId IdType="pubmed">23468546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocca M.A., Amato M.P., De Stefano N., Enzinger C., Geurts J.J., Penner I.K., Rovira A., Sumowski J.F., Valsasina P., Filippi M. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015;14:302&#x2013;317. doi: 10.1016/S1474-4422(14)70250-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70250-9</ArticleId><ArticleId IdType="pubmed">25662900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464:529&#x2013;535. doi: 10.1038/nature08983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08983</ArticleId><ArticleId IdType="pmc">PMC2927852</ArticleId><ArticleId IdType="pubmed">20336135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Grossman R.I., Babb J.S., Rabin M.L., Mannon L.J., Kolson D.L. Age-related total gray matter and white matter changes in normal adult brain. Part II: Quantitative magnetization transfer ratio histogram analysis. Am. J. Neuroradiol. 2002;23:1334&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976246</ArticleId><ArticleId IdType="pubmed">12223374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockhart S.N. Structural Imaging Measures of Brain Aging. Neuropsychol. Rev. 2014;24:271&#x2013;289. doi: 10.1007/s11065-014-9268-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-014-9268-3</ArticleId><ArticleId IdType="pmc">PMC4163469</ArticleId><ArticleId IdType="pubmed">25146995</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCarli C., Massaro J., Harvey D., Hald J., Tullberg M., Au R., Beiser A., D&#x2019;Agostino R., Wolf P.A. Measures of brain morphology and infarction in the framingham heart study: Establishing what is normal. Neurobiol. Aging. 2005;26:491&#x2013;510. doi: 10.1016/j.neurobiolaging.2004.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2004.05.004</ArticleId><ArticleId IdType="pubmed">15653178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakkenberg B., Gundersen H.J.G. Neocortical Neuron Number in Humans: Effect of Sex and Age. J. Comp. Neurol. 1997;384:312&#x2013;320. doi: 10.1002/(SICI)1096-9861(19970728)384:2&lt;312::AID-CNE10&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19970728)384:2&lt;312::AID-CNE10&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">9215725</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman S.H., Kandel R., Cruz L., Rozkalne A., Newell K., Frosch M.P., Hedley-whyte E.T., Joseph J., Lipsitz L., Hyman B.T. Preservation of Neuronal Number Despite Age-Related Cortical Brain Atrophy in Elderly Subjects Without Alzheimer Disease. J. Neuropathol. Exp. Neurol. 2008;67:1205&#x2013;1212. doi: 10.1097/NEN.0b013e31818fc72f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818fc72f</ArticleId><ArticleId IdType="pmc">PMC2734185</ArticleId><ArticleId IdType="pubmed">19018241</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark J., Paul D., Dorothy G., Juan C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer &#x2019; s disease. Lancet. 1994;344:769&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">7916070</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning-Dixon F.M., Brickman A.M., Cheng J.C., Alexopoulos G.S. Aging of cerebral white matter: A review of MRI findings. Int. J. Geriatr. Psychiatry. 2009;24:109&#x2013;117. doi: 10.1002/gps.2087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2087</ArticleId><ArticleId IdType="pmc">PMC2631089</ArticleId><ArticleId IdType="pubmed">18637641</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A. The Effects of Normal Aging on Nerve Fibers and Neuroglia in the Central Nervous System. J. Neurocytol. 2002;31:581&#x2013;593. doi: 10.1023/A:1025731309829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025731309829</ArticleId><ArticleId IdType="pubmed">14501200</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D.C., Polk T.A., Mikels J.A., Taylor S.F., Marshuetz C. Cerebral aging: Integration of brain and behavioral models of cognitive function. Dialogues Clin. Neurosci. 2001;3:151&#x2013;165. doi: 10.31887/DCNS.2001.3.3/dcpark.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2001.3.3/dcpark</ArticleId><ArticleId IdType="pmc">PMC3181659</ArticleId><ArticleId IdType="pubmed">22034448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A.D., Chacon-De-La-Rocha I., Pieropan F., Papanikolau M., Azim K., Butt A.M. Keeping the ageing brain wired: A role for purine signalling in regulating cellular metabolism in oligodendrocyte progenitors. Pfl&#xfc;gers Arch.-Eur. J. Physiol. 2021;473:775&#x2013;783. doi: 10.1007/s00424-021-02544-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-021-02544-z</ArticleId><ArticleId IdType="pmc">PMC8076121</ArticleId><ArticleId IdType="pubmed">33712969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A.D., Butt A.M., Azim K. Resolving the age-related decline in central nervous system myelin turnover and drug discovery for oligodendroglial rejuvenation. Neural Regen. Res. 2022;17:2677&#x2013;2678. doi: 10.4103/1673-5374.338995.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.338995</ArticleId><ArticleId IdType="pmc">PMC9165362</ArticleId><ArticleId IdType="pubmed">35662206</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A. The effects of normal aging on myelinated nerve fibers in monkey central nervous system. Front. Neuroanat. 2009;3:1&#x2013;10. doi: 10.3389/neuro.05.011.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.05.011.2009</ArticleId><ArticleId IdType="pmc">PMC2713738</ArticleId><ArticleId IdType="pubmed">19636385</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C.R., Markus H.S. Evidence for cortical &#x201c;disconnection&#x201d; as a mechanism of age-related cognitive decline. Neurology. 2001;57:632&#x2013;638. doi: 10.1212/WNL.57.4.632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.4.632</ArticleId><ArticleId IdType="pubmed">11524471</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean D.C., Hurley S.A., Kecskemeti S.R., O&#x2019;Grady J.P., Canda C., Davenport-Sis N.J., Carlsson C.M., Zetterberg H., Blennow K., Asthana S., et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 2017;74:41&#x2013;49. doi: 10.1001/jamaneurol.2016.3232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3232</ArticleId><ArticleId IdType="pmc">PMC5195903</ArticleId><ArticleId IdType="pubmed">27842175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad M., Stanley J.A., Raz N. Adult age differences in subcortical myelin content are consistent with protracted myelination and unrelated to diffusion tensor imaging indices. Neuroimage. 2016;143:26&#x2013;39. doi: 10.1016/j.neuroimage.2016.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.08.047</ArticleId><ArticleId IdType="pmc">PMC5124541</ArticleId><ArticleId IdType="pubmed">27561713</ArticleId></ArticleIdList></Reference><Reference><Citation>Denissen S., Engemann D.A., De Cock A., Costers L., Baijot J., Laton J., Penner I.K., Grothe M., Kirsch M., D&#x2019;hooghe M.B., et al. Brain age as a surrogate marker for cognitive performance in multiple sclerosis. Eur. J. Neurol. 2022;29:3039&#x2013;3049. doi: 10.1111/ene.15473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15473</ArticleId><ArticleId IdType="pmc">PMC9541923</ArticleId><ArticleId IdType="pubmed">35737867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann T., van der Meer D., Doan N.T., Schwarz E., Lund M.J., Agartz I., Aln&#xe6;s D., Barch D.M., Baur-Streubel R., Bertolino A., et al. Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nat. Neurosci. 2019;22:1617&#x2013;1623. doi: 10.1038/s41593-019-0471-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0471-7</ArticleId><ArticleId IdType="pmc">PMC6823048</ArticleId><ArticleId IdType="pubmed">31551603</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;gest&#xf8;l E.A., Kaufmann T., Nygaard G.O., Beyer M.K., Sowa P., Nordvik J.E., Kolsk&#xe5;r K., Richard G., Andreassen O.A., Harbo H.F., et al. Cross-sectional and longitudinal MRI brain scans reveal accelerated brain aging in multiple sclerosis. Front. Neurol. 2019;10:450. doi: 10.3389/fneur.2019.00450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00450</ArticleId><ArticleId IdType="pmc">PMC6503038</ArticleId><ArticleId IdType="pubmed">31114541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole J.H., Raffel J., Friede T., Eshaghi A., Brownlee W.J., Chard D., De Stefano N., Enzinger C., Pirpamer L., Filippi M., et al. Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm. Ann. Neurol. 2020;88:93&#x2013;105. doi: 10.1002/ana.25746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25746</ArticleId><ArticleId IdType="pubmed">32285956</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupa K., Bekiesinska-Figatowska M. Congenital and acquired abnormalities of the corpus callosum: A pictorial essay. Biomed Res. Int. 2013;2013:265619. doi: 10.1155/2013/265619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/265619</ArticleId><ArticleId IdType="pmc">PMC3763572</ArticleId><ArticleId IdType="pubmed">24027754</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan N.M., Yarnykh V.L., Hippe D.S., Owen J.P., Huber E., Zhao T.C., Kuhl P.K. Myelin development in cerebral gray and white matter during adolescence and late childhood. Neuroimage. 2021;227:117678. doi: 10.1016/j.neuroimage.2020.117678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117678</ArticleId><ArticleId IdType="pmc">PMC8214999</ArticleId><ArticleId IdType="pubmed">33359342</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M., Lecca D., Coppolino G.T., Parravicini C., Abbracchio M.P., Fumagalli M., Lecca D., Coppolino G.T., Parravicini C., Abbracchio M.P. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine. Adv. Exp. Med. Biol. 2017;19:169&#x2013;192. doi: 10.1007/5584_2017_92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2017_92</ArticleId><ArticleId IdType="pubmed">28828731</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt A.M., Papanikolaou M., Rivera A. Physiology of oligodendroglia. Adv. Exp. Med. Biol. 2019;1775:117&#x2013;128. doi: 10.1007/978-981-13-9913-8_5.,.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-9913-8_5.,</ArticleId><ArticleId IdType="pubmed">31583586</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppolino G.T., Marangon D., Negri C., Menichetti G., Fumagalli M., Gelosa P., Dimou L., Furlan R., Lecca D., Abbracchio M.P. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination. Glia. 2018;66:1118&#x2013;1130. doi: 10.1002/glia.23305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23305</ArticleId><ArticleId IdType="pmc">PMC5900886</ArticleId><ArticleId IdType="pubmed">29424466</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigan&#xf2; F., Schneider S., Cimino M., Bonfanti E., Gelosa P., Sironi L., Abbracchio M.P., Dimou L. GPR17 expressing NG2-Glia: Oligodendrocyte progenitors serving as a reserve pool after injury. Glia. 2016;64:287&#x2013;299. doi: 10.1002/glia.22929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22929</ArticleId><ArticleId IdType="pubmed">26464068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A.D., Pieropan F., Chacon-De-La-Rocha I., Lecca D., Abbracchio M.P., Azim K., Butt A.M. Functional genomic analyses highlight a shift in Gpr17-regulated cellular processes in oligodendrocyte progenitor cells and underlying myelin dysregulation in the aged mouse cerebrum. Aging Cell. 2021;20:e13335. doi: 10.1111/acel.13335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13335</ArticleId><ArticleId IdType="pmc">PMC8045941</ArticleId><ArticleId IdType="pubmed">33675110</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann B., Baror R., Zhao C., Segel M., Dietmann S., Rawji K.S., Foerster S., McClain C.R., Chalut K., van Wijngaarden P., et al. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell Stem Cell. 2019;25:473&#x2013;485.e8. doi: 10.1016/j.stem.2019.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.08.015</ArticleId><ArticleId IdType="pmc">PMC6863391</ArticleId><ArticleId IdType="pubmed">31585093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartzokis G. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer&#x2019;s disease. Neurobiol. Aging. 2004;25:5&#x2013;18. doi: 10.1016/j.neurobiolaging.2003.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2003.03.001</ArticleId><ArticleId IdType="pubmed">14675724</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrabady S.E., Rizvi B., Goldman J.E., Brickman A.M. White matter changes in Alzheimer&#x2019;s disease: A focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 2018;6:22. doi: 10.1186/s40478-018-0515-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0515-3</ArticleId><ArticleId IdType="pmc">PMC5834839</ArticleId><ArticleId IdType="pubmed">29499767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanai S.A., Saini V., Benedict R.H.B., Zivadinov R., Teter B.E., Ramanathan M., Weinstock-Guttman B. Aging and multiple sclerosis. Mult. Scler. 2016;22:717&#x2013;725. doi: 10.1177/1352458516634871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458516634871</ArticleId><ArticleId IdType="pubmed">26895718</ArticleId></ArticleIdList></Reference><Reference><Citation>Love S. Demyelinating diseases. J. Clin. Pathol. 2006;59:1151&#x2013;1159. doi: 10.1136/jcp.2005.031195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2005.031195</ArticleId><ArticleId IdType="pmc">PMC1860500</ArticleId><ArticleId IdType="pubmed">17071802</ArticleId></ArticleIdList></Reference><Reference><Citation>van Langelaar J., Rijvers L., Smolders J., van Luijn M.M. B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers. Front. Immunol. 2020;11:760. doi: 10.3389/fimmu.2020.00760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00760</ArticleId><ArticleId IdType="pmc">PMC7225320</ArticleId><ArticleId IdType="pubmed">32457742</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C.T. Childhood autoimmune neurologic diseases of the central nervous system. Neurol. Clin. 2003;21:745&#x2013;764. doi: 10.1016/S0733-8619(03)00007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0733-8619(03)00007-0</ArticleId><ArticleId IdType="pubmed">14743647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivneva T.A. Mechanisms underlying the process of demyelination in multiple sclerosis. Neurophysiology. 2009;41:365&#x2013;373. doi: 10.1007/s11062-010-9114-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11062-010-9114-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhib-Jalbut S. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis. Neurology. 2007;68:13&#x2013;21. doi: 10.1212/01.wnl.0000275228.13012.7b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000275228.13012.7b</ArticleId><ArticleId IdType="pubmed">17548563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuerten S., Lanz T.V., Lingampalli N., Lahey L.J., Kleinschnitz C., M&#xe4;urer M., Schroeter M., Braune S., Ziemssen T., Ho P.P., et al. Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients. Proc. Natl. Acad. Sci. USA. 2020;117:21512&#x2013;21518. doi: 10.1073/pnas.2011249117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2011249117</ArticleId><ArticleId IdType="pmc">PMC7474673</ArticleId><ArticleId IdType="pubmed">32817492</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H., Ma Q., Li C., Liu R., Zhao L., Wang W., Zhang P., Liu X., Gao G., Liu F., et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 2020;9:1123&#x2013;1130. doi: 10.1080/22221751.2020.1770129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnumakkara A.B., Rana V., Parama D., Banik K., Girisa S., Henamayee S., Thakur K.K., Dutta U., Garodia P., Gupta S.C., et al. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci. 2021;284:119201. doi: 10.1016/j.lfs.2021.119201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119201</ArticleId><ArticleId IdType="pmc">PMC7884924</ArticleId><ArticleId IdType="pubmed">33607159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S., Tandon M., Podury S., Prasad A., Wen S., Guthrie G., Kakara M., Jaiswal S., Subedi R., Elkhooly M., et al. COVID-19 and neuroinflammation: A literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2. J. Neurol. 2021;268:4448&#x2013;4478. doi: 10.1007/s00415-021-10611-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10611-9</ArticleId><ArticleId IdType="pmc">PMC8131883</ArticleId><ArticleId IdType="pubmed">34009454</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks W. Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology. Curr. Pharm. Des. 2005;11:973&#x2013;984. doi: 10.2174/1381612053381684.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612053381684</ArticleId><ArticleId IdType="pubmed">15777248</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;bel K., Ruck T., Meuth S.G. Cytokine signaling in multiple sclerosis: Lost in translation. Mult. Scler. J. 2018;24:432&#x2013;439. doi: 10.1177/1352458518763094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458518763094</ArticleId><ArticleId IdType="pubmed">29512406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Song F., Fernandez-Escobar A., Luo G., Wang J.-H., Sun Y. The Properties of Cytokines in Multiple Sclerosis: Pros and Cons. Am. J. Med. Sci. 2018;356:552&#x2013;560. doi: 10.1016/j.amjms.2018.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2018.08.018</ArticleId><ArticleId IdType="pubmed">30447707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.Y., Zhang W., Roehrl V.B., Roehrl M.W., Roehrl M.H. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19. bioRxiv. 2021 doi: 10.1101/2021.04.05.438500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.05.438500</ArticleId></ArticleIdList></Reference><Reference><Citation>Winchester N., Calabrese C., Calabrese L.H. The intersection of COVID-19 and autoimmunity: What is our current understanding? Pathog. Immun. 2021;6:31&#x2013;54. doi: 10.20411/pai.v6i1.417.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v6i1.417</ArticleId><ArticleId IdType="pmc">PMC8097827</ArticleId><ArticleId IdType="pubmed">33969248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.H., Huang Y.H., Chuang Y.H., Peng C.M., Wang L.C., Lin Y.T., Chiang B.L. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. J. Med. Virol. 2005;77:1&#x2013;7. doi: 10.1002/jmv.20407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20407</ArticleId><ArticleId IdType="pmc">PMC7166512</ArticleId><ArticleId IdType="pubmed">16032747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A. Covid-19 and autoimmunity Michael. Autoimmun. Rev. J. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzaruso C., Carlo Stella N., Mariani G., Nai C., Coppola A., Naldani D., Gallotti P. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin. Rheumatol. 2020;39:2095&#x2013;2097. doi: 10.1007/s10067-020-05180-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05180-7</ArticleId><ArticleId IdType="pmc">PMC7251560</ArticleId><ArticleId IdType="pubmed">32462425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsson M., Asztely F., Hejnebo S., Axelsson M., Malmestr&#xf6;m C., Olausson T., Lycke J. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Ann. Clin. Transl. Neurol. 2022;9:1296&#x2013;1301. doi: 10.1002/acn3.51609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51609</ArticleId><ArticleId IdType="pmc">PMC9349599</ArticleId><ArticleId IdType="pubmed">35713508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna G.B.M.C.M.K.M.H.G. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology. 2003;42:200&#x2013;213. doi: 10.1093/rheumatology/keg080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keg080</ArticleId><ArticleId IdType="pubmed">12595612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent M., Alvarez F., Vogt E., Fyffe R., Ng A.K., Rote N. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J. Rheumatol. 1997;24:1725&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">9292795</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos M., de Carvalho J., Brotto M., Bonfa E., Rocha F. Peripheral neuropathy in patients with primary antiphospholipid (Hughes&#x2019;) syndrome. Lupus. 2010;19:583&#x2013;590. doi: 10.1177/0961203309354541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309354541</ArticleId><ArticleId IdType="pubmed">20156929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S.W.X., Fong S.W., Young B.E., Chan Y.H., Lee B., Amrun S.N., Chee R.S., Yeo N.K., Tambyah P., Pada S., et al. Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021;8:ofab156. doi: 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijlers A.J.C., Meijer K.A., Van Geest Q., Geurts J.J.G., Schoonheim M.M. Determinants of cognitive impairment in patients with multiple sclerosis with and without atrophy. Radiology. 2018;288:544&#x2013;551. doi: 10.1148/radiol.2018172808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2018172808</ArticleId><ArticleId IdType="pubmed">29786489</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbo H.F., Gold R., Tintora M. Sex and gender issues in multiple sclerosis. Ther. Adv. Neurol. Disord. 2013;6:237&#x2013;248. doi: 10.1177/1756285613488434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285613488434</ArticleId><ArticleId IdType="pmc">PMC3707353</ArticleId><ArticleId IdType="pubmed">23858327</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbak S.G., Anisenkova A.Y., Mosenko S.V., Glotov O.S., Chernov A.N., Apalko S.V., Urazov S.P., Garbuzov E.Y., Khobotnikov D.N., Klitsenko O.A., et al. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients. Front. Immunol. 2021;12:745515. doi: 10.3389/fimmu.2021.745515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.745515</ArticleId><ArticleId IdType="pmc">PMC8631447</ArticleId><ArticleId IdType="pubmed">34858403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigdelou B., Sepand M.R., Najafikhoshnoo S., Negrete J.A.T., Sharaf M., Ho J.Q., Sullivan I., Chauhan P., Etter M., Shekarian T., et al. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front. Immunol. 2022;13:2077. doi: 10.3389/fimmu.2022.890517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.890517</ArticleId><ArticleId IdType="pmc">PMC9196863</ArticleId><ArticleId IdType="pubmed">35711466</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Yuan X., Gao F., Zhao B., Ding L., Huan M., Liu C., Jiang L. High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients. Front. Immunol. 2022;13:899930. doi: 10.3389/fimmu.2022.899930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.899930</ArticleId><ArticleId IdType="pmc">PMC9295452</ArticleId><ArticleId IdType="pubmed">35865540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P.G.E. Viral encephalitis: Causes, differential diagnosis, and management. Neurol. Pract. 2004;75:i10&#x2013;i15. doi: 10.1136/jnnp.2003.034280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.034280</ArticleId><ArticleId IdType="pmc">PMC1765650</ArticleId><ArticleId IdType="pubmed">14978145</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurnher M.M., Thurnher S.A., M&#xfc;hlbauer B., Hainfellner J.A., Steuer A., Fleischmann D., Trattnig S., Budka H., Schindler E. Progressive multifocal leukoencephalopathy in AIDS: Initial and follow-up CT and MRI. Neuroradiology. 1997;39:611&#x2013;618. doi: 10.1007/s002340050478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002340050478</ArticleId><ArticleId IdType="pubmed">9335057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet T.M., Del Valle L., Khalili K. Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J. Cell. Physiol. 2002;191:249&#x2013;256. doi: 10.1002/jcp.10096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.10096</ArticleId><ArticleId IdType="pubmed">12012320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood&#x2013;brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan R., Zhang Q., Anthony S.M., Zhou Y., Zou X., Cassell M., Perlman S. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proc. Natl. Acad. Sci. USA. 2020;117:15902&#x2013;15910. doi: 10.1073/pnas.2003432117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003432117</ArticleId><ArticleId IdType="pmc">PMC7355048</ArticleId><ArticleId IdType="pubmed">32571951</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641&#x2013;1647. doi: 10.1161/01.STR.27.9.1641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.27.9.1641</ArticleId><ArticleId IdType="pubmed">8784142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. Remyelination is critical for white matter stroke recovery. Eur. J. Biomed. Res. 2015;1:18&#x2013;22. doi: 10.18088/ejbmr.1.4.2015.pp18-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.18088/ejbmr.1.4.2015.pp18-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Kisel A.A., Akulov A.E., Atochin D.N., Kudabaeva M.S., Glazacheva V.Y., Svetlik M.V., Medvednikova Y.A., Mustafina L.R., Yarnykh V.L. Quantitative assessment of demyelination in ischemic stroke in vivo using macromolecular proton fraction mapping. J. Cereb. Blood Flow Metab. 2018;38:919&#x2013;931. doi: 10.1177/0271678X18755203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18755203</ArticleId><ArticleId IdType="pmc">PMC5987939</ArticleId><ArticleId IdType="pubmed">29372644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewar D., Underhill S.M., Goldberg M.P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab. 2003;23:263&#x2013;274. doi: 10.1097/01.WCB.0000053472.41007.F9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.WCB.0000053472.41007.F9</ArticleId><ArticleId IdType="pubmed">12621301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing L., He Q., Zhang J.Z., Andy Li P. Temporal profile of astrocytes and changes of oligodendrocyte-based myelin following middle cerebral artery occlusion in diabetic and non-diabetic rats. Int. J. Biol. Sci. 2013;9:190&#x2013;199. doi: 10.7150/ijbs.5844.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.5844</ArticleId><ArticleId IdType="pmc">PMC3584915</ArticleId><ArticleId IdType="pubmed">23459858</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Gubskiy I.L., Kudabaeva M.S., Namestnikova D.D., Kisel A.A., Anan&#x2019;ina T.V., Tumentceva Y.A., Mustafina L.R., Yarnykh V.L. Long-term monitoring of chronic demyelination and remyelination in a rat ischemic stroke model using macromolecular proton fraction mapping. J. Cereb. Blood Flow Metab. 2021;41:2856&#x2013;2869. doi: 10.1177/0271678X211020860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X211020860</ArticleId><ArticleId IdType="pmc">PMC8756474</ArticleId><ArticleId IdType="pubmed">34107787</ArticleId></ArticleIdList></Reference><Reference><Citation>Etherton M.R., Wu O., Giese A., Lauer A., Boulouis G., Mills B., Cloonan L., Donahue K.L., Copen W., Schaefer P., et al. White Matter Integrity and Early Outcomes After Acute Ischemic Stroke. Transl. Stroke Res. 2019;10:630&#x2013;638. doi: 10.1007/s12975-019-0689-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-019-0689-4</ArticleId><ArticleId IdType="pubmed">30693424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg M.D., Hedley-Whyte E.T., Richardson E.P. Hypoxic-Ischemic Leukoencephalopathy in Man. Arch. Neurol. 1976;33:5&#x2013;14. doi: 10.1001/archneur.1976.00500010007002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1976.00500010007002</ArticleId><ArticleId IdType="pubmed">1247396</ArticleId></ArticleIdList></Reference><Reference><Citation>Anan&#x2019;ina T., Kisel A., Kudabaeva M., Chernysheva G., Smolyakova V., Usov K., Krutenkova E., Plotnikov M., Khodanovich M. Neurodegeneration, Myelin Loss and Glial Response in the Three-Vessel Global Ischemia Model in Rat. Int. J. Mol. Sci. 2020;21:6246. doi: 10.3390/ijms21176246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176246</ArticleId><ArticleId IdType="pmc">PMC7504277</ArticleId><ArticleId IdType="pubmed">32872364</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun G., Hak J.F., Coze S., Kaphan E., Carvelli J., Girard N., Stellmann J.P. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis? Neurol. Neuroimmunol. Neuroinflamm. 2020;7:4&#x2013;6. doi: 10.1212/NXI.0000000000000777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000777</ArticleId><ArticleId IdType="pmc">PMC7286652</ArticleId><ArticleId IdType="pubmed">32444427</ArticleId></ArticleIdList></Reference><Reference><Citation>Belani P., Schefflein J., Kihira S., Rigney B., Delman B.N., Mahmoudi K., Mocco J., Majidi S., Yeckley J., Aggarwal A., et al. COVID-19 Is an independent risk factor for acute ischemic stroke. Am. J. Neuroradiol. 2020;41:1361&#x2013;1364. doi: 10.3174/ajnr.A6650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6650</ArticleId><ArticleId IdType="pmc">PMC7658882</ArticleId><ArticleId IdType="pubmed">32586968</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDougall M., El-Hajj Sleiman J., Beauchemin P., Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front. Immunol. 2022;13:871276. doi: 10.3389/fimmu.2022.871276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.871276</ArticleId><ArticleId IdType="pmc">PMC9102605</ArticleId><ArticleId IdType="pubmed">35572514</ArticleId></ArticleIdList></Reference><Reference><Citation>Novi G., Rossi T., Pedemonte E., Saitta L., Rolla C., Roccatagliata L., Inglese M., Farinini D. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:4&#x2013;6. doi: 10.1212/NXI.0000000000000797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000797</ArticleId><ArticleId IdType="pmc">PMC7286650</ArticleId><ArticleId IdType="pubmed">32482781</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdi S., Ghorbani A., Fatehi F. The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms. J. Neurol. Sci. 2020;416:117001. doi: 10.1016/j.jns.2020.117001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117001</ArticleId><ArticleId IdType="pmc">PMC7301801</ArticleId><ArticleId IdType="pubmed">32590204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chougar L., Shor N., Weiss N., Galanaud D., Leclercq D., Mathon B., Belkacem S., Str&#xf6;er S., Burrel S., Boutolleau D., et al. Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations. Radiology. 2020;297:E313&#x2013;E323. doi: 10.1148/radiol.2020202422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202422</ArticleId><ArticleId IdType="pmc">PMC7370354</ArticleId><ArticleId IdType="pubmed">32677875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahammedi A., Saba L., Vagal A., Leali M., Rossi A., Gaskill M., Sengupta S., Zhang B., Carriero A., Bachir S., et al. Imaging of neurologic disease in hospitalized patients with COVID-19: An italian multicenter retrospective observational study. Radiology. 2020;297:E270&#x2013;E273. doi: 10.1148/radiol.2020201933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201933</ArticleId><ArticleId IdType="pmc">PMC7587295</ArticleId><ArticleId IdType="pubmed">32437313</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzalone N., Castellano A., Scotti R., Scandroglio A.M., Filippi M., Ciceri F., Tresoldi M., Falini A. Multifocal laminar cortical brain lesions: A consistent MRI finding in neuro-COVID-19 patients. J. Neurol. 2020;267:2806&#x2013;2809. doi: 10.1007/s00415-020-09966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09966-2</ArticleId><ArticleId IdType="pmc">PMC7275660</ArticleId><ArticleId IdType="pubmed">32506390</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson P., Alshafai L., Krings T. Neuroimaging findings in patients with COVID-19. Am. J. Neuroradiol. 2020;41:1380&#x2013;1383. doi: 10.3174/ajnr.A6630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6630</ArticleId><ArticleId IdType="pmc">PMC7658900</ArticleId><ArticleId IdType="pubmed">32527843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., de S&#xe8;ze J., Ferr&#xe9; J.-C., Maamar A., Nicol C.-B., Collange O., Bonneville F., Adam G., Martin-Blondel G., et al. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020;297:E242&#x2013;E251. doi: 10.1148/radiol.2020202222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., Derman A., Lui Y.W., Raz E., Loh J.P., Hagiwara M., Borja M.J., Zan E., Fatterpekar G.M. COVID-19&#x2013;associated Diffuse Leukoencephalopathy and Microhemorrhages. Radiology. 2020;297:E223&#x2013;E227. doi: 10.1148/radiol.2020202040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202040</ArticleId><ArticleId IdType="pmc">PMC7507998</ArticleId><ArticleId IdType="pubmed">32437314</ArticleId></ArticleIdList></Reference><Reference><Citation>Scullen T., Keen J., Mathkour M., Dumont A.S., Kahn L. Coronavirus 2019 (COVID-19)eAssociated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience. World Neurosurg. 2020;141:e437&#x2013;e446. doi: 10.1016/j.wneu.2020.05.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.05.192</ArticleId><ArticleId IdType="pmc">PMC7255727</ArticleId><ArticleId IdType="pubmed">32474092</ArticleId></ArticleIdList></Reference><Reference><Citation>Klironomos S., Tzortzakakis A., Kits A., &#xd6;hberg C., Kollia E., Ahoromazdae A., Almqvist H., Aspelin &#xc5;., Martin H., Ouellette R., et al. Nervous system involvement in coronavirus disease 2019: Results from a retrospective consecutive neuroimaging cohort. Radiology. 2020;297:E324&#x2013;E334. doi: 10.1148/radiol.2020202791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202791</ArticleId><ArticleId IdType="pmc">PMC7393954</ArticleId><ArticleId IdType="pubmed">32729812</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcic L., Marcic M., Kojundzic S.L., Marcic B., Capkun V., Vukojevic K. Personalized approach to patient with mri brain changes after sars-cov-2 infection. J. Pers. Med. 2021;11:442. doi: 10.3390/jpm11060442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11060442</ArticleId><ArticleId IdType="pmc">PMC8224015</ArticleId><ArticleId IdType="pubmed">34063824</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage. 2002;17:1429&#x2013;1436. doi: 10.1006/nimg.2002.1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1267</ArticleId><ArticleId IdType="pubmed">12414282</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K.B., Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain. Magn. Reson. Med. 1997;37:34&#x2013;43. doi: 10.1002/mrm.1910370107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.1910370107</ArticleId><ArticleId IdType="pubmed">8978630</ArticleId></ArticleIdList></Reference><Reference><Citation>Deoni S.C.L.L., Rutt B.K., Arun T., Pierpaoli C., Jones D.K. Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn. Reson. Med. 2008;60:1372&#x2013;1387. doi: 10.1002/mrm.21704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.21704</ArticleId><ArticleId IdType="pubmed">19025904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang D., Kim D.H., Du Y.P. In vivo multi-slice mapping of myelin water content using T2* decay. Neuroimage. 2010;52:198&#x2013;204. doi: 10.1016/j.neuroimage.2010.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.04.023</ArticleId><ArticleId IdType="pubmed">20398770</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma G., Duhamel G., De Bazelaire C., Alsop D.C. Magnetization transfer from inhomogeneously broadened lines: A potential marker for myelin. Magn. Reson. Med. 2015;73:614&#x2013;622. doi: 10.1002/mrm.25174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25174</ArticleId><ArticleId IdType="pmc">PMC4378005</ArticleId><ArticleId IdType="pubmed">24604578</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma G., Girard O.M., Prevost V.H., Grant A.K., Duhamel G., Alsop D.C. Interpretation of magnetization transfer from inhomogeneously broadened lines (ihMT) in tissues as a dipolar order effect within motion restricted molecules. J. Magn. Reson. 2015;260:67&#x2013;76. doi: 10.1016/j.jmr.2015.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmr.2015.08.024</ArticleId><ArticleId IdType="pubmed">26408956</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevost V.H., Girard O.M., Mchinda S., Varma G., Alsop D.C., Duhamel G. Optimization of inhomogeneous magnetization transfer (ihMT) MRI contrast for preclinical studies using dipolar relaxation time (T1D) filtering. NMR Biomed. 2017;30:e3706. doi: 10.1002/nbm.3706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3706</ArticleId><ArticleId IdType="pubmed">28195663</ArticleId></ArticleIdList></Reference><Reference><Citation>Dula A.N., Gochberg D.F., Valentine H.L., Valentine W.M., Does M.D. Multiexponential T2, magnetization transfer, and quantitative histology in white matter tracts of rat spinal cord. Magn. Reson. Med. 2010;63:902&#x2013;909. doi: 10.1002/mrm.22267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.22267</ArticleId><ArticleId IdType="pmc">PMC2852261</ArticleId><ArticleId IdType="pubmed">20373391</ArticleId></ArticleIdList></Reference><Reference><Citation>Janve V.A., Zu Z., Yao S.Y., Li K., Zhang F.L., Wilson K.J., Ou X., Does M.D., Subramaniam S., Gochberg D.F. The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage. 2013;74:298&#x2013;305. doi: 10.1016/j.neuroimage.2013.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.02.034</ArticleId><ArticleId IdType="pmc">PMC3995162</ArticleId><ArticleId IdType="pubmed">23481461</ArticleId></ArticleIdList></Reference><Reference><Citation>Samsonov A., Alexander A.L., Mossahebi P., Wu Y.C., Duncan I.D., Field A.S. Quantitative MR imaging of two-pool magnetization transfer model parameters in myelin mutant shaking pup. Neuroimage. 2012;62:1390&#x2013;1398. doi: 10.1016/j.neuroimage.2012.05.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.05.077</ArticleId><ArticleId IdType="pmc">PMC3408843</ArticleId><ArticleId IdType="pubmed">22664569</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill H.R., Rostomily R.C., Mikheev A.M., Yuan C., Yarnykh V.L. Fast bound pool fraction imaging of the in vivo rat brain: Association with myelin content and validation in the C6 glioma model. Neuroimage. 2011;54:2052&#x2013;2065. doi: 10.1016/j.neuroimage.2010.10.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.10.065</ArticleId><ArticleId IdType="pmc">PMC3008309</ArticleId><ArticleId IdType="pubmed">21029782</ArticleId></ArticleIdList></Reference><Reference><Citation>Odrobina E.E., Lam T.Y.J., Pun T., Midha R., Stanisz G.J. MR properties of excised neural tissue following experimentally induced demyelination. NMR Biomed. 2005;18:277&#x2013;284. doi: 10.1002/nbm.951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.951</ArticleId><ArticleId IdType="pubmed">15948233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Sun S.W., Liang H.F., Song S.K., Gochberg D.F. The MT pool size ratio and the DTI radial diffusivity may reflect the myelination in shiverer and control mice. NMR Biomed. 2009;22:480&#x2013;487. doi: 10.1002/nbm.1358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1358</ArticleId><ArticleId IdType="pmc">PMC3711249</ArticleId><ArticleId IdType="pubmed">19123230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Sun S.W., Liang H.F., Song S.K., Gochberg D.F. Quantitative magnetization transfer measured pool-size ratio reflects optic nerve myelin content in ex vivo mice. Magn. Reson. Med. 2009;61:364&#x2013;371. doi: 10.1002/mrm.21850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.21850</ArticleId><ArticleId IdType="pmc">PMC2632728</ArticleId><ArticleId IdType="pubmed">19165898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausch M., Tofts P., Lervik P., Walmsley A., Mir A., Schubart A., Seabrook T. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*. Mult. Scler. 2009;15:16&#x2013;27. doi: 10.1177/1352458508096006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458508096006</ArticleId><ArticleId IdType="pubmed">18971220</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmierer K., Tozer D.J., Scaravilli F., Altmann D.R., Barker G.J., Tofts P.S., Miller D.H. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J. Magn. Reson. Imaging. 2007;26:41&#x2013;51. doi: 10.1002/jmri.20984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.20984</ArticleId><ArticleId IdType="pmc">PMC2063415</ArticleId><ArticleId IdType="pubmed">17659567</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiessen J.D., Zhang Y., Zhang H., Wang L., Buist R., Del Bigio M.R., Kong J., Li X.M., Martin M. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination. NMR Biomed. 2013;26:1562&#x2013;1581. doi: 10.1002/nbm.2992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2992</ArticleId><ArticleId IdType="pubmed">23943390</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumova A.V., Akulov A.E., Khodanovich M.Y., Yarnykh V.L. High-resolution three-dimensional macromolecular proton fraction mapping for quantitative neuroanatomical imaging of the rodent brain in ultra-high magnetic fields. Neuroimage. 2017;147:985&#x2013;993. doi: 10.1016/j.neuroimage.2016.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.09.036</ArticleId><ArticleId IdType="pmc">PMC5303642</ArticleId><ArticleId IdType="pubmed">27646128</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Pishchelko A.O., Glazacheva V.Y., Pan E.S., Akulov A.E., Svetlik M.V., Tyumentseva Y.A., Anan&#x2019;ina T.V. Yarnykh Vasily Leonidovich Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction. Cells. 2019;8:1204. doi: 10.3390/cells8101204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101204</ArticleId><ArticleId IdType="pmc">PMC6830095</ArticleId><ArticleId IdType="pubmed">31590363</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y.Y., Sorokina I.V.V., Glazacheva V.Y.Y., Akulov A.E.E., Nemirovich-Danchenko N.M.M., Romashchenko A.V.V., Tolstikova T.G.G., Mustafina L.R.R., Yarnykh V.L.L. Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model. Sci. Rep. 2017;7:srep46686. doi: 10.1038/srep46686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46686</ArticleId><ArticleId IdType="pmc">PMC5402392</ArticleId><ArticleId IdType="pubmed">28436460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L., Krutenkova E.P., Aitmagambetova G., Henson L.K.J., Piedmont H., Repovic P., Mayadev A., Qian P., Gangadharan B. Iron-insensitive quantitative assessment of subcortical gray matter demyelination in multiple sclerosis using macromolecular proton fraction. Am. J. Neuroradiol. 2018;39:618&#x2013;625. doi: 10.3174/ajnr.A5542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5542</ArticleId><ArticleId IdType="pmc">PMC5895485</ArticleId><ArticleId IdType="pubmed">29439122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L.L., Bowen J.D.D., Samsonov A., Repovic P., Mayadev A., Qian P., Gangadharan B., Keogh B.P.P., Maravilla K.R.R., Henson L.K.J., et al. Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis. Radiology. 2014;274:210&#x2013;220. doi: 10.1148/radiol.14140528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.14140528</ArticleId><ArticleId IdType="pmc">PMC4314118</ArticleId><ArticleId IdType="pubmed">25208343</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie E.C., Cross D.J., Yarnykh V.L., Richards T., Martin N.M., Pagulayan K., Hoff D., Hart K., Mayer C., Tarabochia M., et al. Neuroimaging, Behavioral, and Psychological Sequelae of Repetitive Combined Blast/Impact Mild Traumatic Brain Injury in Iraq and Afghanistan War Veterans. J. Neurotrauma. 2014;31:425&#x2013;436. doi: 10.1089/neu.2013.2952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2013.2952</ArticleId><ArticleId IdType="pmc">PMC3934596</ArticleId><ArticleId IdType="pubmed">24102309</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova L.P., Yarnykh V.L., Parshukova D.A., Kornetova E.G., Semke A.V., Usova A.V., Pishchelko A.O., Khodanovich M.Y., Ivanova S.A. Global hypomyelination of the brain white and gray matter in schizophrenia: Quantitative imaging using macromolecular proton fraction. Transl. Psychiatry. 2021;11:365. doi: 10.1038/s41398-021-01475-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01475-8</ArticleId><ArticleId IdType="pmc">PMC8257619</ArticleId><ArticleId IdType="pubmed">34226491</ArticleId></ArticleIdList></Reference><Reference><Citation>Korostyshevskaya A.M., Savelov A.A., Papusha L.I., Druy A.E., Yarnykh V.L. Congenital medulloblastoma: Fetal and postnatal longitudinal observation with quantitative MRI. Clin. Imaging. 2018;52:172&#x2013;176. doi: 10.1016/j.clinimag.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2018.06.001</ArticleId><ArticleId IdType="pubmed">30096555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarnykh V.L.L., Prihod&#x2019;ko I.Y.Y., Savelov A.A.A., Korostyshevskaya A.M.M. Quantitative assessment of normal fetal brain myelination using fast macromolecular proton fraction mapping. Am. J. Neuroradiol. 2018;39:1341&#x2013;1348. doi: 10.3174/ajnr.A5668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5668</ArticleId><ArticleId IdType="pmc">PMC7655450</ArticleId><ArticleId IdType="pubmed">29748201</ArticleId></ArticleIdList></Reference><Reference><Citation>Korostyshevskaya A.M.M., Prihod&#x2019;ko I.Y.Y., Savelov A.A.A., Yarnykh V.L.L. Direct comparison between apparent diffusion coefficient and macromolecular proton fraction as quantitative biomarkers of the human fetal brain maturation. J. Magn. Reson. Imaging. 2019;50:52&#x2013;61. doi: 10.1002/jmri.26635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.26635</ArticleId><ArticleId IdType="pmc">PMC6579650</ArticleId><ArticleId IdType="pubmed">30635965</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>